While there is clinical data stating that IFN-β is a beneficial therapeutic for the treatment of ulcerative colitis, there are also reports that this therapy in multiple sclerosis or chronic hepatitis patients can worsen disease, or even spontaneously induce IBD39–41. The gene discussed is IFNB1; the disease is ulcerative colitis.